Stratec SE (XTER:SBS) FFO


XTER:SBS Stratec SE XTER:SBS
67 GF Score
Price €17.70
GF Value €32.21
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Stratec SE FFO?

FFO (Funds from operations) only applies to REITs.

XTER:SBS
67GF Score
Stratec SE XTER:SBS
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Stratec SE (XTER:SBS) Overvalued in 2026?

Based on GuruFocus' analysis, Stratec SE stock appears to be undervalued. The current stock price of €17.70 is trading 45% below its estimated GF Value™ of €32.21. GuruFocus considers Stratec SE to be Significantly Undervalued.

Key valuation signals for XTER:SBS:

  • FFO:
  • GF Value™: €32.21 vs. price of €17.70 (45% below fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the XTER:SBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Stratec SE Business Description

Other Exchanges 0RAR:UKSBSG:Austria
Address Gewerbestrasse 37, Birkenfeld, RP, DEU, 75217
Stratec SE designs and manufactures automation solutions for regulated laboratory markets. STRATEC acts as an OEM partner to players in the in-vitro diagnostics and life sciences markets. The Group's product range includes both hardware solutions, software solutions, and related consumables, as well as independently marketed consumables. These products are mostly combined into fully integrated system solutions and often receive market approval together with partners' reagents.
67GF Score

Get the complete analysis for XTER:SBS

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.70
Price
€32.21
GF Value